0001209191-21-043555.txt : 20210628 0001209191-21-043555.hdr.sgml : 20210628 20210628184021 ACCESSION NUMBER: 0001209191-21-043555 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210624 FILED AS OF DATE: 20210628 DATE AS OF CHANGE: 20210628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERRIFIELD C ANN CENTRAL INDEX KEY: 0001247224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 211055067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-24 0 0001419600 Flexion Therapeutics Inc FLXN 0001247224 MERRIFIELD C ANN C/O FLEXION THERAPEUTICS 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 1 0 0 0 Common Stock 2021-06-24 4 A 0 4500 0.00 A 19000 D Stock option (right to buy) 9.22 2021-06-24 4 A 0 7000 0.00 A 2031-06-23 Common Stock 7000 7000 D Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan. The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant. /s/ Mark S. Levine, Attorney-in-Fact 2021-06-28